Chen, Helen X.
National Institutes of Health · The University of Texas MD Anderson Cancer Center · Wayne State University · The Barbara Ann Karmanos Cancer Institute · National Cancer Institute
3 papers on CoChatORCID 0000-0001-9959-8417
Most cited papers
- Verified
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine
Neuroblastoma Research and TreatmentsGlioma Diagnosis and Treatment
Cited by 1,835
- Verified
Adverse effects of anticancer agents that target the VEGF pathway
Chen, H. X., & Cleck, J. N. (2009) · Nature Reviews Clinical Oncology
Angiogenesis and VEGF in CancerChemotherapy-related skin toxicity
Cited by 560
- Verified
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors
Naing, A., LoRusso, P., Fu, S., Hong, D. S., Anderson, P., Benjamin, R. S., Ludwig, J., Chen, H. X., Doyle, L. A., & Kurzrock, R. (2012) · Clinical Cancer Research
Sarcoma Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancer
Cited by 205
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free